Monitored effects of physical activity on fetal heart rate with a wireless non-invasive monitor
Official title: Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device
Run by Balgrist University Hospital · NCT06813859 · Data updated 2026-11-12
This study tests whether a wireless, non-invasive device can reliably track fetal heart rate during exercise in pregnant athletes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | Balgrist University Hospital Academic / other |
| Locations | 2 sites (Zurich, Canton of Zurich and 1 other locations) |
| Status | Recruiting |
| Started | June 30, 2025 |
| Main results expected | October 31, 2026 |
| Study ends | February 27, 2027 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT06813859 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy pregnant women 18–44 years old, 28+0 to 34+0 weeks gestation, active exercisers (>4 hours/week on at least 2 weekdays) with informed consent.
✕Probably not a fit
Pregnant individuals outside the specified gestational window, with pre-existing pregnancy complications, or those not meeting the fitness criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study will first assess whether the Nemo Healthcare Monitoring System can accurately measure fetal heart rate compared with standard Doppler ultrasound and whether measurements are consistent within and between observers. It will also explore how maternal exercise affects fetal heart rate patterns, blood flow, and placental–fetal circulation. If the initial step shows validity and reliability, a larger study will examine changes in these parameters across different levels of exertion. The project uses an observational design with an exercise testing intervention in otherwise healthy pregnant participants between 28 and 34 weeks gestation.
Why it matters
Potential benefit: If successful, the device could enable continuous, non-invasive fetal monitoring during physical activity.
How similar studies have gone: Previous work with CTG devices suggests feasibility for continuous fetal monitoring, but the specific wireless, non-invasive approach and exercise context is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Presence of signed informed consent form * healthy pregnant active female over the age of 18 years and below 45 years * sporting activity \>4h/week on 2 or more weekdays * single pregnancy, between 28+0 and 34+0 weeks of pregnancy Exclusion Criteria: * No signed informed consent form or revocation of consent * pre-existing pregnancy complications
Where it's running
-
Balgrist University Hospital
Zurich, Canton of Zurich, Switzerland Recruiting -
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: Nora Wieloch, Dr. med.
- Email: nora.wieloch@balgrist.ch
- Phone: 0041443861111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dark chocolate to prompt a non-reactive fetal NST to become reactive
This will test whether one 30 g serving of dark chocolate (≥80% cocoa) given to pregnant women at 36–41 weeks with a non-reactive NST helps the fetal heart-rate tracing become reactive within 20 minutes compared with a sugar-free white chocolate placebo.
-
Improving heart assessment in fetuses and newborns
This study is testing new ways to check the heart health of unborn babies and newborns to help prevent serious problems during delivery.
-
Oxygen supplementation for mothers during labor to help babies in distress
This study is testing if giving extra oxygen to mothers during labor can help their babies who are in distress feel better and avoid complications.
-
New sensor for monitoring fetal health during late pregnancy
This study is testing a new non-adhesive sensor to see if it can accurately monitor the heart rates of pregnant women and their babies during late pregnancy.
-
Ophthalmic Artery Doppler to predict labor problems before induction
This study tests whether measuring the ophthalmic artery Doppler in pregnant people at term who are being induced can help predict intrapartum fetal distress.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.